Methylation of p16(INK4A) in primary gynecologic malignancy

Cancer Letters

Volumn 136, Issue 2, 1999, Pages 231-235

  Wong, Y F ^a   Chung, T K H ^a   Cheung, T H ^a   Nobori, T ^b   Yu, A L ^c   Yu, J ^d   Batova, A ^d   Lai, K W H ^a   Chang, A M Z ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cervical; Endometrial; Methylation; Ovarian; p16(INK4A)

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 9; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DNA METHYLATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE MAPPING; GENETIC ANALYSIS; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; UTERINE CERVIX CARCINOMA; CARCINOMA; ENDOMETRIUM TUMOR; FEMALE GENITAL TRACT TUMOR; GENETICS; OVARY TUMOR; UTERINE CERVIX TUMOR;

DNA; PROTEIN P16INK4A;

ADULT; CARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; DNA METHYLATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 0032587282     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00327-9     Document Type: Article

References (14)

1. INK4B alterations in primary gynecologic malignancy. Gynecol. Oncol. 65:1997;319-324.
2. Cairns P., Polascik T.J., Eby Y., Tokino K., Califano J., Merlo A., Mao L., Herath J., Jenkins R., Westra W. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet. 11:1995;210-212.
3. Wong Y.F., Cheung T.K., Chung T.K.H., Chan M.K.M., Chang A.M.Z. Expression of p16IK4 and Rb Genes in cervical neoplasm. J. Lower Genital Tract Dis. 1:1997;240-244.
4. Laird P.W., Jaenisch R. DNA methylation and cancer. Hum. Mol. Genet. 3:1994;1487-1495.
5. Gonzaler-Zulueta M., Beneder C.M., Yang A.S., Nguyen T., Beart R.W., Van Tornout J.M., Jones P.A. Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55:1995;4531-4535.
6. INK4B. Cancer Res. 56:1996;722-727.
7. Batova A., Diccianni M.B., Yu J.C., Nobori T., Link M.P., Pullen J., Yu A.L. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res. 57:1997;832-836.
8. Sambrook J., Fritch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
9. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C., Baylin S.B., Sidransky D. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1:1995;686-692.
10. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.J., Davidson N.E., Sidransky D., Baylin S.B. Inactivation of CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancer. Cancer Res. 55:1995;4525-4530.
11. Milde-Langosch K., Ocon E., Becker G., Loning T. p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors. Int. J. Cancer. 79:1998;61-65.
12. Ryan A., Al-Jehani R.M., Mulligan K.T., Jacobs I.J. No evidence exists for methylation inactivation of the p16 tumor supressor gene in ovarian carcinogenesis. Gynecol. Oncol. 68:1998;14-17.
13. Marchini S., Codegoni A.M., Bonazzi C., Chiari S., Broggini M. Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumors. Br. J. Cancer. 76:1997;46-49.
14. Shih Y.C., Kerr J., Liu J., Hurst T., Khoo S.K., Ward B., Wainwright B., Chenevevix-Trench G. Rare mutation and no hypermethylation at the CDKN2A locus in epithelial ovarian tumors. Int. J. Cancer. 70:1997;508-511.